Bill Text: CA AB2871 | 2023-2024 | Regular Session | Amended
Bill Title: Overdose fatality review teams.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-04-25 - Re-referred to Com. on APPR. [AB2871 Detail]
Download: California-2023-AB2871-Amended.html
Amended
IN
Assembly
April 24, 2024 |
Introduced by Assembly Member Maienschein |
February 15, 2024 |
LEGISLATIVE COUNSEL'S DIGEST
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NOBill Text
The people of the State of California do enact as follows:
SECTION 1.
Division 10.1 (commencing with Section 11675) is added to the Health and Safety Code, to read:DIVISION 10.1. OVERDOSE FATALITY REVIEW TEAMS
11675.
(a) A county may establish an interagency overdose fatality review team to assist local agencies in identifying and reviewing overdose fatalities, facilitate communication among the various persons and agencies involved in overdose fatalities, and integrate local overdose prevention efforts through strategic planning, data dissemination, and community collaboration.11676.
An overdose fatality review team may be comprised of, but not limited to, all of the following:11677.
(a) An oral or written communication or a document shared within or produced by an overdose fatality review team related to an overdose fatality review is confidential and not subject to disclosure or discovery by a third party.11678.
An organization represented on an overdose fatality review team may share information in its possession concerning the decedent who is the subject of the review, information received from a person who was in contact with the decedent, or other information deemed by the organization to be pertinent to the review with other members of the team. Information shared by an organization with other members of a team is confidential.(a)(1)Written and oral information may be disclosed to an overdose fatality review team established pursuant to this division. The team may make a request in writing for the information sought and a person with information of the kind described in paragraph (3) may rely on the request in determining whether information may be disclosed to the team.
(2)An individual or agency that has information governed by this division is not required to disclose that information.
(3)The following information may be disclosed pursuant to this division:
(A)Notwithstanding Section 56.10 of the Civil Code, medical information.
(B)Notwithstanding Section 5328 of the Welfare and Institutions Code, mental health information.
(C) (D) (E)Notwithstanding Section 12300 of the Welfare and Institutions Code, records relating to in-home supportive services, unless disclosure is prohibited by federal law.11679.
(a) Consistent with paragraph (9) of subdivision (b) of Section 56.10 of the Civil Code, a provider of health care, as defined in Section 56.05 of the Civil Code, or a covered entity, as defined in Section 160.103 of Title 45 of the Code of Federal Regulations, shall provide to the members of the county overdose fatality review team any information, including protected health information, and mental health records excluding psychotherapy notes, in its possession that is directly related to the review authorized under Section 11675 about the individual involved in the case. The provision of information under this
subdivision is a disclosure required by law, which may be made only to the extent permitted under subdivision (a) of Section 164.512 of Title 45 of the Code of Federal Regulations. The information disclosed shall include substance use disorder patient records only to the extent permitted by Part 2 (commencing with Section 2.1) of Title 42 of the Code of Federal Regulations.(b)Written and oral information may be disclosed under this section notwithstanding Sections 2263, 2918, 4982, and 6068 of the Business and Professions Code, the lawyer-client privilege protected by Article 3 (commencing with Section 950) of Chapter 4 of Division 8 of the Evidence Code, the physician-patient privilege protected by Article 6
(commencing with Section 990) of Chapter 4 of Division 8 of the Evidence Code, and the psychotherapist-patient privilege protected by Article 7 (commencing with Section 1010) of Chapter 4 of Division 8 of the Evidence Code.